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Abstract  Breast  cancer  is  the  most  common  tumor  in  women  and  the  ﬁrst  cause  of  death  for
malignancy  in  the  female.  Bile  ducts  are  not  among  the  common  sites  of  metastasis  from  breast
cancer. Few  cases  of  obstructive  jaundice  due  to  metastatic  breast  cancer  have  been  described
in the  literature  and  they  mostly  resulted  from  widespread  liver  metastases  that  eventually
involved  the  bile  ducts.  We  report  an  exceptional  case  of  ampullary  metastasis  in  the  absence
of liver  metastases.
Sporadic  reports  have  been  published  about  the  involvement  of  the  ampulla  by  breast  cancer
metastasis.  This  case  emphasizes  the  need  to  consider  this  diagnosis  in  women  presenting  with
obstructive  jaundice,  especially  when  there  is  a  clinical  possibility  of  breast  cancer.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALAVRAS-CHAVE
Neoplasias  da  Mama;
Metástase  Ampular  de  Neoplasia  da  Mama:  Uma  Causa  Rara  de  Icterícia  ObstrutivaAmpola
Hepatopancreática;
Icterícia
Obstrutiva/etiologia;
Metástase  Neoplásica
Resumen  O  cancro  da  mama  é  o  tumor  mais  comum  em  mulheres  e  a  principal  causa  de
morte por  neoplasia  nesta  populac¸ão.  A  via  biliar  não  é  um  local  comum  de  metastizac¸ão
desta neoplasia.  Poucos  casos  de  icterícia  obstrutiva  devido  a  metástases  mamárias  têm  sido
descritos  na  literatura  e  ocorrem  principalmente  devido  a  metástases  hepáticas  que  comprimem
a via  biliar.  Relatamos  um  caso  excepcional  de  metástase  ampular  na  ausência  de  metástases
hepáticas.∗ Corresponding author.
E-mail address: silviagiestas@gmail.com (S. Giestas).
ttp://dx.doi.org/10.1016/j.jpge.2016.03.001
341-4545/© 2016 Sociedade Portuguesa de Gastrenterologia. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Existem  apenas  relatos  esporádicos  do  envolvimento  da  ampola  por  metástase  mamárias.  Este
caso enfatiza  a  necessidade  de  considerar  este  diagnóstico  perante  um  quadro  de  icterícia
obstrutiva,  especialmente  em  doentes  com  possível  neoplasia  mamária.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es
un art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Figure  1  Computed  tomography  showed  an  ampullary  mass
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t1. Introduction
Breast  cancer  is  the  most  common  malignancy  in  women,
with  over  a  million  newly  diagnosed  cases  each  year  and
being  one  of  the  leading  causes  of  cancer  death  among
them.1--3
In  10%  of  the  cases  distant  metastases  are  already  present
at  the  time  of  the  diagnosis.4--6 Breast  cancer  metastases
occur  through  contiguous,  lymphatic  and  hematogenous
spread.  Common  sites  of  metastasis  include  bone,  lung,
lymph  nodes,  liver  and  brain.  Virtually  every  site  of  the
human  body  can  be  targeted  by  hematogenous  spread  of
breast  cancer.  However,  metastases  to  the  digestive  tract,
the  kidneys  and  retroperitoneal  organs  have  only  been
occasionally  reported.4--6 Gastrointestinal  tract  involvement
is  detected  in  only  10%  of  all  the  cases.4--6 Widespread
liver  metastases  that  compress  or  inﬁltrate  the  bile  ducts
can  sometimes  cause  obstructive  jaundice,  whilst  a  direct
metastatic  involvement  of  the  extrahepatic  bile  ducts  in
absence  of  hepatic  lesions  is  exceptional.4--6
We  report  a  singular  case  of  obstructive  jaundice  due  to
a  metastatic  breast  cancer  to  the  ampulla  of  Vater.  To  the
best  of  our  knowledge  and  review  of  the  literature  there
have  been  only  few  similar  reports.7--10
This  case  emphasize  that  diagnosis  can  be  difﬁcult  and
controversial  when  metastasis  from  breast  cancer  occurs  at
uncommon  sites,  but  quick  and  accurate  diagnosis  is  needed
for  an  adequate  treatment  choice.
2. Case presentation
A  59-year-old  female  was  admitted  to  the  emergency
department  with  mucocutaneous  jaundice  associated  with
pruritus.  No  dark  urine,  acholic  stools,  abdominal  pain,
fever,  anorexia  or  weight  loss  were  present.  Personal  his-
tory  included  systemic  lupus  erythematosus  (treated  with
hydroxychloroquine  sulfate  and  mycophenolate  mofetil),
type  2 diabetes  mellitus  non-insulin  treated  and  a  breast
lump  (detected  about  a  month  ago  in  breast  cancer
screening  mammography)  under  investigation  (histology
ongoing).  The  laboratory  tests  showed  an  obstructive  pat-
tern  with  total  bilirubin  9  mg/dL,  direct  bilirubin  6.4  mg/dL,
aspartate  aminotransferase  126  IU/L,  alanine  aminotrans-
ferase  208  IU/L,  gamma  glutamyl  transpeptidase  796  IU/L,
alkaline  phosphatase  726  IU/L  and  negative  inﬂammatory
parameters.  Blood  tumor  markers  (cancer  antigen  19.9  and
carcinoembryonic  antigen)  were  within  normal  ranges.  The
abdominal  ultrasound  study  was  limited  by  bowel  gas  inter-
position  but  allowed  view  marked  dilatation  of  intrahepatic
r
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tith 13  mm  suggestive  of  ampullary  adenoma.
ile  ducts  and  common  bile  duct  14  mm  and  could  not
eﬁne  the  cause  of  obstruction.  Abdominal  tomography
onﬁrmed  dilatation  of  hepatic  bile  ducts  (common  bile
uct  with  15  mm  without  evidence  of  choledocholitiasis)
nd  showed  an  ampullary  mass  with  13  mm  of  diame-
er  suggestive  of  ampullary  adenoma  without  suspicious
bdominal  lymph  nodes  (Fig.  1). Endoscopic  retrograde
holangiopancreatography  (ERCP)  showed  papilla  of  Vater
ith  moderately  increased  volume  and  irregular  mucosal
uggestive  of  congestive  ampullary  adenoma.  Biopsies  were
erformed  and  two  plastic  biliary  stents  were  placed.  His-
ology  showed  inﬁltration  by  invasive  ductal  carcinoma  of
he  breast  (Fig.  2).  During  hospitalization  the  histology
f  the  breast  nodule  revealed  an  invasive  breast  carci-
oma  and  the  patient  initiated  chemotherapy  (including
ranstuzumab).  Further  evaluation  with  chest  tomography
nd  radionuclide  bone  scanning  revealed  the  presence  of
one  metastases.  For  better  palliation,  three  months  after
he  plastic  stent  implantation,  patient  underwent  repeat
RCP  with  the  placement  of  a  metal  stent  due  to  its  bet-
er  efﬁciency.  At  discharge  and  several  weeks  later  the
epeated  laboratory  tests  revealed  regression  of  cholestasis.
he  patient  succumbed  to  metastatic  disease  1  year  later  of
he  diagnostic  without  jaundice  or  abnormal  liver  function
ests.
302  
Figure  2  Histology  of  the  ampulla  of  Vater:  papilla  showed
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is  shorter  than  4  months,  if  it  is  longer  than  4  months  thennﬁltration  by  invasive  ductal  carcinoma  of  the  breast.
. Discussion
reast  cancer  is  the  most  commonly  diagnosed  cancer  world-
ide,  with  more  than  1,384,000  cases  detected  each  year.
t  is  the  main  cause  of  death  from  cancer  in  females  and  the
econd  in  the  general  population,  after  lung  cancer.1--3
Distant  metastases  of  breast  carcinoma  are  present  in
bout  10%  of  patients  at  the  time  of  diagnosis,  while  30%  of
atients  will  develop  metastatic  disease  following  surgery
nd/or  chemotherapy,  radiotherapy  or  endocrine  therapy.3
The  most  common  sites  of  breast  cancer  metastases
re  the  bone,  lung,  liver  and  brain,  while  the  involvement
f  gastrointestinal  tract  is  rare  and  can  pose  a  diagnostic
hallenge.4--6 Metastatic  breast  cancer  can  cause  obstruc-
ive  jaundice  when  multiple  liver  lesions  are  present,  the
ile  duct  is  compressed  by  enlarged  lymph  nodes  or,  more
arely,  when  the  head  of  the  pancreas  is  involved.4--6 The  bil-
ary  tract  is  very  rarely  affected  by  metastases  in  general,
nd  in  these  cases,  colorectal  cancer  is  the  most  frequent
alignancy  involved.  Other  reported  primary  tumors  causing
etastatic  biliary  obstruction  include  malignant  melanoma,
ymphoma,  gallbladder,  stomach,  esophagus,  liver,  ovary,
ervix,  uterus,  muscle,  kidney,  prostate,  bone  and  brain.
solated  breast  cancer  metastasis  to  the  biliary  tract,  gall-
ladder  and  Vater  ampulla  are  exceptional.4--6 It  is  important
o  recognize  this  group  of  patients  because  in  patients  with
ormal  liver  function,  relief  of  biliary  obstruction  using  sur-
ical  bypass  or  biliary  stenting  extends  their  survival  to  over
 year,  in  comparison  to  those  with  liver  metastases,  whose
ean  survival  is  only  about  1  month.11--13
By  reviewing  the  literature  there  were  only  a  few  cases
f  extrahepatic  biliary  tract  metastasis  from  breast  cancer
nvolving  the  periampullary  area.7--10 A  permanent  feature  of
ll  the  reports  available  in  the  literature  is  that  the  diagno-
is  was  not  achieved  nor  suspected  before  endoscopy  biopsy
nd/or  surgery.  Similarly,  in  the  majority  of  the  cases  there
as  a  long  interval  between  the  diagnosis  of  the  primary
umor  and  the  development  of  metastases  affecting  the
i
c
tS.  Giestas  et  al.
iliary  tract.  This  timing  can  make  it  hard  to  suspect  a
elationship  between  the  breast  cancer  and  the  biliary
isease.7--10 In  our  case  this  was  the  ﬁrst  evidence  of
etastatic  breast  cancer.  Patients  with  a  history  of  malig-
ancy  found  to  have  obstructive  jaundice  from  an  ampullary
ass  should  undergo  further  investigation  to  determine
rimary  biliary  cancer  versus  metastatic  disease  in  order
o  provide  appropriate  surgical  and  medical  management.
owadays,  numerous  modalities  such  as  extracorporeal
ltrasonography  (US),  esophagogastroduodenoscopy,  biopsy,
omputed  tomography  (TC),  magnetic  resonance  (MRI),
ndoscopic  ultrasonography  (EUS),  ERCP,  intraductal  US
nd  angiography  are  available  for  diagnosing  ampullary
eoplasms.  Appropriate  and  efﬁcient  selection  of  such
odalities  is  necessary  for  lessening  procedure-related
omplications  as  well  as  the  burden  on  the  patients.14
t  is  not  always  possible  to  distinguish  adenoma  from
arcinoma  or  metastatic  involvement  of  the  ampulla  with
uodenoscopy  only,  and  histological  evaluation  by  forceps
iopsy  is  mandatory  for  establishment  of  a  deﬁnitive  diagno-
is.  The  diagnostic  accuracy  of  forceps  biopsy  in  ampullary
eoplasms  reportedly  ranges  from  47  to  95%.14 Immunohis-
ochemistry  plays  a  key  role  for  indicating  the  histological
ype  of  the  tumor,  since  the  metastases  of  breast  carcinoma
o  the  gastrointestinal  tract  have  an  endoscopic,  radiolog-
cal  and  histological  aspect  similar  to  the  adenocarcinoma
oorly  differentiated  with  signet  ring  cells.10 Tumor  stating
ith  EUS  and/or  intraductal  US  can  provide  useful  infor-
ation  for  making  therapeutic  decisions,  especially  in  the
election  of  patients  for  endoscopic  papillectomy.14 CT/MRI
s  recommended  for  the  detection  of  distant  metastases.
US  can  be  performed  in  a  single  session  with  ERCP,  biopsy
nd  biliary  stent  placement  (if  indicated).14
Patients  with  metastatic  breast  cancer  in  the  biliary  tract
eed  a  long-term  palliative  treatment  strategy.  The  use  of
ovel  chemotherapy,  hormonal  therapy  and  irradiation  in
onjunction  with  biliary  decompression  or  surgical  interven-
ion  may  lead  to  even  more  prolonged  survival  and  improve
uality  of  life.15,16 A  variety  of  chemotherapy  strategies  are
vailable  for  metastatic  breast  cancer  and  should  be  tailored
or  each  patient  along  with  endocrine  therapy  in  tumors
ositive  for  estrogen  and  progesterone  receptors.16--18 HER2
eceptor-positive  metastatic  disease  should  be  treated  with
rastuzumab  in  addition  to  chemotherapy.19
Biliary  stenting  is  a  commonly  used  procedure  in  treating
atients  with  pancreaticobiliary  malignancies,  metastatic
isease  and  external  biliary  compression  by  lymph  nodes.
t  is  used  both  as  a  bridge  to  surgery  in  patients  with
esectable  disease  and  for  palliation  in  those  with  biliary
bstruction  caused  by  inoperable  disease.20,21 For  palliation
ndoscopic  biliary  drainage  is  effective  in  more  than  80%  of
ases.21--25 Multiple  trials  have  demonstrated  that  placement
f  self-expanding  metallic  stents  in  patients  with  malignant
bstruction  of  the  common  bile  duct  offers  higher  techni-
al  and  clinical  success  rates  as  well  as  lower  complication
ates  and  a  superior  cumulative  stent  patency  when  com-
ared  with  plastic  stent  placement.21--25 Initial  insertion  of  a
lastic  stent  is  most  cost-effective  if  patient  life  expectancynitial  insertion  of  a  self-expanding  metallic  stents  is  more
ost-effective.21--25 In  our  case,  we  ﬁrst  placed  a  plastic  stent
o  gain  symptomatic  relief,  but  after  knowing  the  result  of
11
1
1
1
1
1
1
1
1
2
2
2
2
2Ampullary  Metastasis  From  Breast  Cancer  
histology,  we  replaced  it  with  a  metal  one  3  months  after
the  ﬁrst  intervention.
The  present  report  provides  evidence  that  metastases
from  breast  cancer  can  target  the  extrahepatic  bile  ducts  in
the  absence  of  liver  involvement,  and  the  invasion  of  the  bile
duct  wall  can  also  be  the  ﬁrst  sign  of  advanced  disease,  thus
making  the  diagnosis  particularly  difﬁcult.  Although  gas-
trointestinal  involvement  in  breast  cancer  is  rare,  in  patients
with  a  history  of  a  breast  lump,  the  possibility  of  biliary
localization  of  metastatic  disease  should  be  always  consid-
ered  in  the  differential  diagnosis  of  obstructive  jaundice
whose  origin  is  unclear,  especially  because  this  condition  is
amenable  to  palliation  and  improve  survival  rate.
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